Status:

COMPLETED

A Study to Evaluate the Effect of Jaktinib on QT/QTc Interval in Healthy Participants

Lead Sponsor:

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Conditions:

Healthy Participants

Eligibility:

All Genders

18-45 years

Phase:

PHASE1

Brief Summary

To evaluate the effect of Jaktinib Hydrochloride Tablets on QT/QTc interval in healthy subjects after a single oral administration.

Eligibility Criteria

Inclusion

  • Voluntarily sign informed consent, able to comply with the requirements of the study.
  • Age 18-45 years old, both male and female;
  • Weight: male ≥ 50 kg, female ≥ 45 kg, 19 kg/m\^2 ≤ BMI ≤26 kg/m\^2.
  • 12-lead electrocardiogram (ECG) examination, 300 ms≤QTcF\<450 ms, 120 ms≤PR interval ≤200 ms, and QRS duration \<120 ms;
  • The subjects (including male subjects) are willing to voluntarily take effective contraceptive measures within the next 3 months.

Exclusion

  • Have a history of risk factors for torsade de pointes, or have a family history of short QT syndrome, long QT syndrome, unexplained sudden death in young adulthood (≤40 years old), drowning or sudden infant death syndrome in first-degree relatives;
  • Previous history of hyperkalemia, hypokalemia, hypermagnesemia, hypomagnesemia, hypercalcemia or hypocalcemia;
  • Subjects who had donated blood or lost ≥400 mL of blood within 3 months before screening;
  • HBsAg, HCV antibody, HIV antibody, or TP antibody antibody positive.
  • Women with positive blood pregnancy test (applicable to women) or lactating women;
  • Subjects who have other factors that the investigator considers unsuitable for participation in the study.

Key Trial Info

Start Date :

March 19 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 18 2024

Estimated Enrollment :

32 Patients enrolled

Trial Details

Trial ID

NCT06193148

Start Date

March 19 2024

End Date

June 18 2024

Last Update

December 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The First Affiliated Hospital of Soochow University

Suzhu, Jiangsu, China